Journal
JOURNAL OF CLINICAL MEDICINE
Volume 9, Issue 6, Pages -Publisher
MDPI
DOI: 10.3390/jcm9061944
Keywords
coronavirus disease 2019 (COVID-19); angiotensin-converting enzyme inhibitor; myocardial injury; cardiovascular diseases; cardiac biomarkers; arrhythmias
Categories
Ask authors/readers for more resources
A highly pathogenic human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been recently recognized in Wuhan, China, as the cause of the coronavirus disease 2019 (COVID-19) outbreak which has spread rapidly from China to other countries in the world, causing a pandemic with alarming morbidity and mortality. The emerging epidemiological data about COVID-19 patients suggest an association between cardiovascular diseases (CVD) and SARS-CoV-2 infection, in term of clinical features at hospital admission and prognosis for disease severity. The aim of our review is to describe the cardiological features of COVID-19 patients at admission, the acute cardiac presentation, the clinical outcome for patients with underlying CVD and the pharmacological implications for disease management.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available